Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Trial watch: Opioid receptor blocker shows promise in Phase II depression trial.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • الموضوع:
      UNITED States
    • الموضوع:
      ALKERMES Inc.
    • نبذة مختصرة :
      The article focuses on the Phase II trial which discusses the efficacy of the opioid receptor blocker among patients with depression. It states that the said trial assesses the efficacy and safety of the ALKS 5461 opioid receptor from Alkermes. Results show the significant effect of the opioid receptor in treating patients with depression.